Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics (Q38500850)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 20, 2010

Language	Label	Description	Also known as
English	Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics	scientific article published on August 20, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

author name string

Chih-Ken Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yu-Shu Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Shao-Chun Ree

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Cheng-Cheng Hsiao

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20732372

21 June 2024

publication date

20 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0278584610003155?httpAccept=text/xml

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

https://api.elsevier.com/content/article/PII:S0278584610003155?httpAccept=text/plain

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1495-1499

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The Barnes Akathisia Rating Scale--revisited

2

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

3

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study

4

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

5

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Neuroendocrine response to antipsychotics: effects of drug type and gender

6

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

8

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia

9

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

10

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats

11

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

13

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study

14

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.

15

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole

16

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences

17

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

18

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

The Arizona Sexual Experience Scale (ASEX): reliability and validity

19

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole

20

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

21

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

22

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

A rating scale for extrapyramidal side effects

23

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Elevation of prolactin levels by atypical antipsychotics

24

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Reversal of symptomatic hyperprolactinemia by aripiprazole

25

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers

26

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

27

1 reference

10.1016/J.PNPBP.2010.08.012

https://api.crossref.org/works/10.1016/J.PNPBP.2010.08.012

21 June 2024

Identifiers

10.1016/J.PNPBP.2010.08.012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38500850&oldid=2185390283"